Search Results - "MURANSKI, P"

Refine Results
  1. 1

    Inhibition of TGF-β signaling in genetically engineered tumor antigen-reactive T cells significantly enhances tumor treatment efficacy by Zhang, L, Yu, Z, Muranski, P, Palmer, D C, Restifo, N P, Rosenberg, S A, Morgan, R A

    Published in Gene therapy (01-05-2013)
    “…Transforming growth factor β (TGF-β) is a cytokine with complex biological functions that may involve tumor promotion or tumor suppression. It has been…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Clinical and biological predictors of outcome following relapse of CML post-allo-SCT by Jain, N A, Ito, S, Tian, X, Kurlander, R, Battiwalla, M, Lu, K, Savani, B N, Malkovska, V, Rezvani, K, Le, R Q, Shenoy, A, Hourigan, C S, Keyvanfar, K, Koklanaris, E, Superata, J, Muranski, P, Barrett, A J, Yong, A S M

    Published in Bone marrow transplantation (Basingstoke) (01-02-2015)
    “…Although there are now fewer allo-SCTs performed for CML, leukemic relapse post transplant remains a persistent problem. To better define clinical and…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Large granular lymphocyte (LGL)-like clonal expansions in paroxysmal nocturnal hemoglobinuria (PNH) patients by RISITANO, A. M, MACIEJEWSKI, J. P, MURANSKI, P, WLODARSKI, M, O'KEEFE, C, SLOAND, E. M, YOUNG, N. S

    Published in Leukemia (01-02-2005)
    “…In paroxysmal nocturnal hemoglobinuria (PNH), clonal expansion of glycosylphosphatidylinositol-anchored proteins (GPI-AP)-deficient cells leads to a syndrome…”
    Get full text
    Journal Article
  7. 7

    T Helper 17 Cells Promote Cytotoxic T Cell Activation in Tumor Immunity by Martin-Orozco, Natalia, Muranski, Pawel, Chung, Yeonseok, Yang, Xuexian O., Yamazaki, Tomohide, Lu, Sijie, Hwu, Patrick, Restifo, Nicholas P., Overwijk, Willem W., Dong, Chen

    Published in Immunity (Cambridge, Mass.) (20-11-2009)
    “…Although T helper 17 (Th17) cells have been found in tumor tissues, their function in cancer immunity is unclear. We found that interleukin-17A…”
    Get full text
    Journal Article
  8. 8

    Altered Selection of CD4+ T Cells by Class II MHC Bound with Dominant and Low Abundance Self-Peptides by Gaszewska-Mastalarz, Anna, Muranski, Pawel, Chmielowski, Bartosz, Kraj, Piotr, Ignatowicz, Leszek

    Published in The Journal of immunology (1950) (01-12-2000)
    “…We have investigated the development of CD4(+) T cells in mice expressing low levels of transgenic class II MHC molecules (A(b)) preoccupied with covalent…”
    Get full text
    Journal Article
  9. 9

    Increased Intensity Lymphodepletion Enhances Tumor Treatment Efficacy of Adoptively Transferred Tumor-specific T Cells by WRZESINSKI, Claudia, PAULOS, Chrystal M, KAISER, Andrew, MURANSKI, Pawel, PALMER, Douglas C, GATTINONI, Luca, ZHIYA YU, ROSENBERG, Steven A, RESTIFO, Nicholas P

    Published in Journal of immunotherapy (1997) (2010)
    “…Lymphodepletion before adoptive cell transfer (ACT)-based immunotherapies can enhance anti-tumor responses by augmenting innate immunity, by increasing access…”
    Get full text
    Journal Article
  10. 10

    Adoptive immunotherapy of cancer using CD4 super(+) T cells by Muranski, P, Restifo, N P

    Published in Current opinion in immunology (01-04-2009)
    “…CD4 super(+) T cells are central to the function of the immune system but their role in tumor immunity remains underappreciated. It is becoming clear that…”
    Get full text
    Journal Article
  11. 11

    Identification of novel microRNA signatures linked to acquired aplastic anemia by Hosokawa, Kohei, Muranski, Pawel, Feng, Xingmin, Keyvanfar, Keyvan, Townsley, Danielle M, Dumitriu, Bogdan, Chen, Jichun, Kajigaya, Sachiko, Taylor, James G, Hourigan, Christopher S, Barrett, A John, Young, Neal S

    Published in Haematologica (Roma) (01-12-2015)
    “…Emerging evidence indicates that microRNA control and modulate immunity. MicroRNA have not been investigated in acquired aplastic anemia, a T-cell-mediated…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Inhibition of TGF-[beta] signaling in genetically engineered tumor antigen-reactive T cells significantly enhances tumor treatment efficacy by Zhang, L, Yu, Z, Muranski, P, Palmer, D C, Restifo, N P, Rosenberg, S A, Morgan, R A

    Published in Gene therapy (01-05-2013)
    “…Transforming growth factor [beta] (TGF-[beta]) is a cytokine with complex biological functions that may involve tumor promotion or tumor suppression. It has…”
    Get full text
    Journal Article
  17. 17

    Mature CD4+ T Cells Perceive a Positively Selecting Class II MHC/Peptide Complex in the Periphery by Muranski, Pawel, Chmielowski, Bartosz, Ignatowicz, Leszek

    Published in The Journal of immunology (1950) (15-03-2000)
    “…A repertoire of TCRs is selected in the thymus by interactions with MHC bound to self-derived peptides. Whether self peptides bound to MHC influence the…”
    Get full text
    Journal Article
  18. 18

    Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8 super(+) T cells via TLR4 signaling by Paulos, G M, Wrzesinski, C, Kaiser, A, Hinrichs, C S, Chieppa, M, Cassard, L, Palmer, D C, Boni, A, Muranski, P, Yu, Z, Gattinoni, L, Antony, P A, Rosenberg, SA, Restifo, N P

    Published in The Journal of clinical investigation (01-08-2007)
    “…Lymphodepletion with total body irradiation (TBI) increases the efficacy of adoptively transferred tumor-specific CD8 super(+) T cells by depleting inhibitory…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Mature CD4 super(+) T Cells Perceive a Positively Selecting Class II MHC/Peptide Complex in the Periphery by Muranski, P, Chmielowski, B, Ignatowicz, L

    Published in The Journal of immunology (1950) (15-03-2000)
    “…A repertoire of TCRs is selected in the thymus by interactions with MHC bound to self-derived peptides. Whether self peptides bound to MHC influence the…”
    Get full text
    Journal Article